Ophthalmic devices are those devices which are used for vision correction or in ophthalmic diagnostic procedures. Ophthalmic laser devices create a uniform and coherent light which can be continuous or pulsed in treating a wide spectrum of diseases involving both the anterior and posterior markets of the eye for correcting refractive disorders. GlobalData uses proprietary data and analytics to provide a comprehensive report on the ophthalmic lasers devices market, including market shares of different players within South Africa. Buy the latest report here.
Smarter leaders trust GlobalData
In 2021, GlobalData’s Market Model methodology determined that the leading player in the ophthalmic lasers market in South Africa was Johnson & Johnson Vision Care followed by Carl Zeiss Meditec, Alcon, Bausch & Lomb, SCHWIND eye-tech-solutions, Iridex, Aurolab and Nidek.
Excimer lasers, femtosecond lasers and YAG lasers are covered under this category.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the ophthalmic lasers devices market within South Africa was expected to be over $7m in 2021.
For the latest complete market share analysis of ophthalmic lasers device market in South Africa, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
